3pbioVIAN, a Navarre-based company specializing in the development and manufacturing (CDMO) of biological drugs to the highest quality standards, has been awarded the international "talent acceleration" award at the prestigious BWB awards in Boston. This recognition highlights the company’s ability to foster scientific talent and develop the skills needed to succeed in the rapidly growing biopharmaceutical industry. The award, which celebrates excellence in training and talent development programs, positions 3pbioVIAN as a leader in implementing innovative solutions to support the growth of its employees. This international recognition underscores the company’s strong commitment to professional development, solidifying its reputation as a leader in the sector.
Raúl Santiago, associate director of learning & development at 3pbioVIAN, as part of the human resources team, has been a key player in the design and implementation of a groundbreaking training program, which has allowed the company to transform its approach to talent development. This approach has created a culture of continuous learning that has equipped its employees with the necessary tools to face the challenges of the future.
The company’s CEO, Dámaso Molero, and CCO, Elena Erroba, accepted the award during the ceremony in Boston. In his speech, Dámaso Molero said: "We are very grateful to the organization for this recognition, which reflects the hard work our team has done in recent years. I must congratulate our learning & development team, who have done an outstanding job, helping us drive radical change in our organization through learning and talent development."
This award marks a significant milestone for 3pbioVIAN, not only for its technical capabilities in the manufacturing of advanced therapies but also for its commitment to developing internal talent, positioning the company as a pioneer in transforming the biopharmaceutical industry. With this recognition, 3pbioVIAN reaffirms its commitment to continue leading the sector through innovative initiatives in training and talent development, paving the way for a new era in the biopharmaceutical industry.